{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:05:04Z","timestamp":1789625104957,"version":"build-2803163510"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>Autoimmune neurological disorders, including myasthenia gravis and autoimmune encephalitis, may occur in association with thymoma, warranting careful neurological surveillance. Generalized thymoma-associated myasthenia gravis (g-TAMG) complicated with anti-\u03b1-amino-3-hydroxy-5-methyl-4 isoxazolepropionic acid receptor (AMPAR) antibody encephalitis is rare, and its clinical features remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patient concerns:<\/jats:title>\n                    <jats:p>A 53-year-old Japanese man was followed up at our department for g-TAMG. The thymoma was classified as B1\/B2 mixed according to the World Health Organization classification. He initially developed insomnia, followed by progressive tremors in both upper limbs, dysphagia, and gait disturbance. He subsequently began to experience repeated falls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>Brain magnetic resonance imaging upon admission revealed hyperintense lesions in the extensive cerebral cortex on fluid-attenuated inversion recovery and diffusion-weighted imaging. During this course, serum and cerebrospinal fluid tested positive for AMPAR antibodies, leading to a diagnosis of AMPAR antibody encephalitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>Intravenous methylprednisolone pulse therapy, intravenous immunoglobulin therapy, and plasma exchange therapy were administered, followed by rituximab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>The neurological prognosis remained poor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Immunotherapy with rituximab for generalized thymoma-associated myasthenia gravis (g-TAMG) associated with AMPAR antibody encephalitis showed no favorable outcomes. The poor prognosis may have been influenced by the fulminant encephalitis type and residual thymic tumor pathology. Although AMPAR antibody encephalitis is a rare complication of thymoma, its involvement should be considered when patients with thymoma develop central nervous system symptoms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050330","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:05:43Z","timestamp":1787331943000},"page":"e50330","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Generalized thymoma-associated myasthenia gravis associated with anti-\u03b1-amino-3-hydroxy-5-methyl-4 isoxazolepropionic acid receptor antibody encephalitis"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4086-8923","authenticated-orcid":false,"given":"Jun","family":"Soma","sequence":"first","affiliation":[{"name":"Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sawada","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Nanbu","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Ando","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Kikuchi-Takeguchi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Multiple Sclerosis Therapeutics, Fukushima Medical University, School of Medicine, Fukushima, Fukushima, Japan"},{"name":"Department of Animal Model Development, Brain Research Institute, Niigata University, Niigata, Niigata, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology and Nephrology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Hokkaido, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/ejcts\/ezv380","article-title":"Myasthenia gravis with thymic epithelial tumour: a retrospective analysis of a Japanese database.","volume":"49","author":"Nakajima","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"e1053","DOI":"10.1212\/NXI.0000000000001053","article-title":"Thymoma and autoimmune encephalitis: clinical manifestations and antibodies.","volume":"8","author":"Guasp","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1097\/JTO.0000000000000300","article-title":"Paraneoplastic disorders in thymoma patients.","volume":"9","author":"Evoli","year":"2014","journal-title":"J Thorac Oncol"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.2006.00608.x","article-title":"Titin and ryanodine receptor antibodies in myasthenia gravis.","volume":"183","author":"Skeie","year":"2006","journal-title":"Acta Neurol Scand Suppl"},{"key":"R6-20260917","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1158\/1078-0432.CCR-04-0735","article-title":"Autoantibody profiles and neurological correlations of thymoma.","volume":"10","author":"Vernino","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"117","DOI":"10.20517\/2347-8659.2016.53","article-title":"Thymoma-associated panencephalitis: a newly emerging paraneoplastic neurologic syndrome.","volume":"4","author":"Nwabuobi","year":"2017","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00441-006-0275-4","article-title":"Role of AMPA receptors in synaptic plasticity.","volume":"326","author":"Sprengel","year":"2006","journal-title":"Cell Tissue Res"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location.","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1001\/jamaneurol.2015.1715","article-title":"Clinical spectrum of encephalitis associated with antibodies against the \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature.","volume":"72","author":"Joubert","year":"2015","journal-title":"JAMA Neurol"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"652820","DOI":"10.3389\/fimmu.2021.652820","article-title":"Anti-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor encephalitis: a review.","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s13760-025-02743-w","article-title":"Anti-AMPA receptor encephalitis combined with myasthenia gravis: a case report.","volume":"125","author":"Huang","year":"2025","journal-title":"Acta Neurol Belg"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients.","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"e14568","DOI":"10.1111\/cns.14568","article-title":"Thymoma-associated autoimmune encephalitis with myasthenia gravis: case series and literature review.","volume":"30","author":"Su","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jneuroim.2015.02.011","article-title":"Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis.","volume":"281","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12883-019-1358-7","article-title":"Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report.","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Neurol"},{"key":"R17-20260917","first-page":"e63239","article-title":"Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antibody encephalitis in an immunosuppressed patient with myasthenia gravis post-thymoma treatment.","volume":"16","author":"Tan","year":"2024","journal-title":"Cureus"},{"key":"R18-20260917","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s10072-016-2680-0","article-title":"Rapidly progressive neurological deterioration in anti-AMPA receptor encephalitis with additional CRMP5 antibodies.","volume":"37","author":"Yang","year":"2016","journal-title":"Neurol Sci"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"e01528","DOI":"10.1002\/brb3.1528","article-title":"Limbic encephalitis associated with AMPA receptor and CRMP5 antibodies: a case report and literature review.","volume":"10","author":"Jia","year":"2020","journal-title":"Brain Behav"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11748-007-0185-8","article-title":"Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.","volume":"56","author":"Okumura","year":"2008","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"R21-20260917","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00000478-200101000-00012","article-title":"Clinical and functional significance of WHO classification on human thymic epithelial neoplasms: a study of 146 consecutive tumors.","volume":"25","author":"Okumura","year":"2001","journal-title":"Am J Surg Pathol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050330","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:01:28Z","timestamp":1789624888000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050330"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":21,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050330","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2026-06-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}